{"product_id":"marubi-pestle-analysis","title":"Guangdong Marubi Biotechnology PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Competitive Advantage Starts with This Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eQuickly grasp how regulatory shifts, market dynamics, and biotech innovation are shaping Guangdong Marubi Biotechnology’s strategic path—our concise PESTLE snapshot highlights key risks and opportunities you can act on immediately; purchase the full PESTLE for the complete, editable analysis and tactical recommendations to inform investments and strategy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Support for Domestic Brands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Chinese government’s Guochao push drives consumer preference toward local brands, with domestic cosmetics' market share rising to 62% in 2024, benefiting Guangdong Marubi Biotechnology’s sales momentum.\u003c\/p\u003e\n\u003cp\u003ePolicy support—including tax incentives and priority in procurement—reduces dependence on foreign conglomerates and helped China’s beauty sector attract RMB 48.6 billion in 2024 R\u0026amp;D and industrial subsidies.\u003c\/p\u003e\n\u003cp\u003ePolitical backing eases Marubi’s access to regional distribution networks and government-led initiatives, accelerating store rollouts that contributed to a 19% year-on-year domestic revenue increase in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Oversight and Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy end-2025 the National Medical Products Administration tightened oversight, with inspections up 28% YoY and fines for noncompliance averaging RMB 1.2m in 2024; Marubi faces stringent registration for functional anti-aging and eye-care ingredients, extending approval timelines by 6–12 months. High compliance reduces recall risk—recalls rose 15% in 2024—and protects revenue, given cosmetics fines and lost sales can cut margins by 3–5 percentage points.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDual Circulation Economic Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpchina dual circulation strategy targeting a gdp growth and stronger domestic consumption supports marubi china-focused skincare model by expanding demand for mid-to-high-end personal care. political measures as the policy package boosting household disposable income urban stimulus addressable market size premium cosmetics. localized supply chain\u003e80% domestic sales mix insulate it from tariff volatility and export headwinds. \n\u003c\/pchina\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustrial Modernization Policies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGuangdong mandates accelerated industrial modernization, pushing Marubi to allocate ~RMB 200–350 million (2024–25 capex) into smart factories and automation to meet provincial targets for high-tech manufacturing and Industry 4.0 adoption.\u003c\/p\u003e\n\u003cp\u003ePolicy-linked tax incentives and grants—up to 10–20% of qualifying investments—have reduced payback periods, enabling faster ROI and reinforcing Marubi’s leadership in the Guangdong biotech corridor.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRMB 200–350M capex (2024–25) for automation\u003c\/li\u003e\n\u003cli\u003e10–20% tax\/grant incentives for industrial upgrading\u003c\/li\u003e\n\u003cli\u003eAligned with Guangdong high-tech manufacturing targets\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrade Policy and Ingredient Sourcing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePolitical shifts in China-EU\/Japan trade relations can raise import tariffs or non-tariff barriers, inflating costs for specialty chemicals—China imported €18.5bn of pharmaceutical precursors from EU in 2024, so disruptions would materially affect Marubi’s input costs.\u003c\/p\u003e\n\u003cp\u003eEscalation in trade barriers would force Marubi to pivot to domestic suppliers; China’s specialty chemical output rose 6.2% in 2024, offering alternatives but with variable quality.\u003c\/p\u003e\n\u003cp\u003eMarubi must balance political alignment and supply security with maintaining ingredient quality—using dual-sourcing, long-term contracts, and potential backward integration to protect product efficacy and margins.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e€18.5bn EU pharmaceutical precursors imports to China (2024)\u003c\/li\u003e\n\u003cli\u003eChina specialty chemical output +6.2% (2024)\u003c\/li\u003e\n\u003cli\u003eMitigations: dual-sourcing, long-term contracts, backward integration\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGuochao lifts Marubi sales; tighter NMPA \u0026amp; RMB200–350M capex reshape margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStrong domestic policy tailwinds (Guochao: domestic cosmetics 62% share in 2024) and Dual Circulation boost Marubi’s sales; tightened NMPA oversight (inspections +28% YoY; avg fine RMB1.2m in 2024) raises compliance costs and extends approvals 6–12 months; Guangdong mandates ~RMB200–350M 2024–25 capex for automation, with 10–20% tax\/grant incentives supporting ROI.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDomestic market share\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNMPA inspections\u003c\/td\u003e\n\u003ctd\u003e+28% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvg fine\u003c\/td\u003e\n\u003ctd\u003eRMB1.2m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex\u003c\/td\u003e\n\u003ctd\u003eRMB200–350M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIncentives\u003c\/td\u003e\n\u003ctd\u003e10–20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how Political, Economic, Social, Technological, Environmental and Legal forces uniquely impact Guangdong Marubi Biotechnology, with data-backed trends, sector-specific examples, and forward-looking insights to help executives, investors and strategists identify risks, opportunities and actionable scenarios for regional market positioning and funding readiness.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, shareable PESTLE snapshot of Guangdong Marubi Biotechnology that highlights regulatory, economic, technological, environmental, and social risks and opportunities for quick alignment in meetings, presentations, and client reports.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGrowth of the Middle Class\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy end-2025 China’s middle class is estimated at ~430–450 million, fueling premium skincare growth projected at CAGR ~9–11% (2022–25); Marubi’s positioning as a high-quality domestic alternative lets it capture value-seeking consumers trading up from mass brands toward premium efficacy at lower price points than global luxury. Rising disposable incomes in Tier 2–3 cities—per capita disposable income up ~7–8% YoY in many provinces in 2024—support geographic expansion and volume upside.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRaw Material Price Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFluctuations in global commodity prices—petrochemical feedstock up 18% YoY in 2024—squeeze Marubi’s gross margins, given heavy use of petroleum-based excipients and specialty bio-actives that rose 12–25% in 2023–24.\u003c\/p\u003e\n\u003cp\u003eMaintaining stable retail pricing amid China’s cosmetics market growth of 6.5% in 2024 forces higher COGS absorption or margin cuts for Marubi.\u003c\/p\u003e\n\u003cp\u003eStrategic stockpiling and multi-year supply contracts (locking prices for 12–36 months) are essential to hedge inflationary input risk and stabilize production costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eShift in Retail Channel Economics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi faces a retail shift to live-streaming and Douyin-led social commerce; in 2024 China live-commerce GMV was about RMB 3.1 trillion, driving firms to reallocate marketing spend. Marubi must earmark larger shares of revenue for digital ads and influencer commissions, compressing gross margins—industry CAC on Douyin averaged RMB 150–300 in 2024 for beauty brands. Containing high CAC in a saturated digital market is a primary economic priority.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumer Spending Sensitivity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDespite a 2024 China beauty market value of about CNY 452 billion, economic uncertainty can shift consumers toward essentials, reducing spend on luxury skincare and slowing premium segment growth.\u003c\/p\u003e\n\u003cp\u003eMarubi’s multi-brand approach, with affordable Chunji, captures lower-price segments—Chunji priced ~30–60% below flagship lines—providing downside protection during downturns.\u003c\/p\u003e\n\u003cp\u003eResilience hinges on value-driven innovation; firms delivering measurable efficacy at mid\/low price points maintain sales when GDP growth slows from 5% to ~3%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 China beauty market ~CNY 452bn\u003c\/li\u003e\n\u003cli\u003eChunji ~30–60% cheaper than flagship\u003c\/li\u003e\n\u003cli\u003eGDP slowdown scenario: 5% → ~3% impacts premium spend\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor Costs and Manufacturing Efficiency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eRising wages in Guangdong—average manufacturing hourly wages up ~6.8% YoY in 2024 to about CNY 27\/hour—push up Marubi’s plant OPEX, prompting ~RMB 120–180m planned capex for automation in 2024–25 to sustain margins.\u003c\/p\u003e\n\u003cp\u003eInvestments in robotics and process optimization aim to cut direct labor intensity by ~20% and improve throughput 15–25% versus 2023 baseline, balancing human capital and tech spend to remain cost-competitive regionally.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 Guangdong manufacturing wages +6.8% YoY to CNY 27\/hr\u003c\/li\u003e\n\u003cli\u003eMarubi automation capex target RMB 120–180m (2024–25)\u003c\/li\u003e\n\u003cli\u003eExpected labor intensity reduction ~20%\u003c\/li\u003e\n\u003cli\u003eThroughput gains 15–25% vs 2023\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRising middle class fuels 9–11% beauty growth as input costs squeeze margins, spurring automation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEconomic tailwinds: growing middle class (~430–450M by end‑2025) and Tier‑2\/3 disposable income +7–8% YoY (2024) support premium\/skincare growth CAGR ~9–11% (2022–25); headwinds: petrochemical feedstock +18% YoY (2024) and bio‑active input +12–25% (2023–24) squeeze margins; Guangdong wages +6.8% (2024) to CNY27\/hr drive RMB120–180m automation capex to cut labor intensity ~20% and boost throughput 15–25%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024–25)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eChina middle class\u003c\/td\u003e\n\u003ctd\u003e430–450M (end‑2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBeauty market\u003c\/td\u003e\n\u003ctd\u003eCNY452bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFeedstock change\u003c\/td\u003e\n\u003ctd\u003e+18% YoY (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGuangdong wage\u003c\/td\u003e\n\u003ctd\u003eCNY27\/hr (+6.8% YoY)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAutomation capex\u003c\/td\u003e\n\u003ctd\u003eRMB120–180m (2024–25)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eGuangdong Marubi Biotechnology PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Guangdong Marubi Biotechnology PESTLE Analysis you’ll receive after purchase—fully formatted, professionally structured, and ready to use for strategy or investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751373582713,"sku":"marubi-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/marubi-pestle-analysis.png?v=1772230717","url":"https:\/\/growthsharematrix.com\/products\/marubi-pestle-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}